Average Co-Inventor Count = 7.26
ph-index = 48
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (98 from 1,147 patents)
98 patents:
1. 12441703 - Carboxamides as modulators of sodium channels
2. 12440481 - Esters and carbamates as modulators of sodium channels
3. 12421251 - Cystic fibrosis transmembrane conductance regulator modulating agents
4. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
5. RE50453 - Indole derivatives as CFTR modulators
6. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator
7. 12319693 - Crystalline forms of CFTR modulators
8. 12281057 - Carboxamides as modulators of sodium channels
9. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator
10. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
11. 12247021 - Substituted tetrahydrofurans as modulators of sodium channels
12. 12122788 - Process of making CFTR modulators
13. 11919887 - Substituted tetrahydrofurans as modulators of sodium channels
14. 11873300 - Crystalline forms of CFTR modulators
15. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators